These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 22621388)

  • 1. Plasma YKL-40: a potential biomarker for psoriatic arthritis?
    Jensen P; Wiell C; Milting K; Poggenborg RP; Østergaard M; Johansen JS; Skov L
    J Eur Acad Dermatol Venereol; 2013 Jul; 27(7):815-9. PubMed ID: 22621388
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum YKL-40 in psoriasis with and without arthritis; correlation with disease activity and high-resolution power Doppler ultrasonographic joint findings.
    Ahmed SF; Attia EA; Saad AA; Sharara M; Fawzy H; El Nahrery EM
    J Eur Acad Dermatol Venereol; 2015 Apr; 29(4):682-8. PubMed ID: 25087779
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel inflammatory markers in psoriasis vulgaris: vaspin, vascular adhesion protein-1 (VAP-1), and YKL-40.
    Ataseven A; Kesli R
    G Ital Dermatol Venereol; 2016 Jun; 151(3):244-50. PubMed ID: 25279492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chitinase-3-Like Protein 1 (YKL-40) Is a New Biomarker of Inflammation in Psoriasis.
    Salomon J; Matusiak Ł; Nowicka-Suszko D; Szepietowski JC
    Mediators Inflamm; 2017; 2017():9538451. PubMed ID: 28932021
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of etanercept on C-reactive protein levels in psoriasis and psoriatic arthritis.
    Strober B; Teller C; Yamauchi P; Miller JL; Hooper M; Yang YC; Dann F
    Br J Dermatol; 2008 Aug; 159(2):322-30. PubMed ID: 18503600
    [TBL] [Abstract][Full Text] [Related]  

  • 6. YKL-40 is a serum biomarker reflecting the severity of cutaneous lesions in psoriatic arthritis.
    Imai Y; Aochi S; Iwatsuki K; Sano H; Yamanishi K
    J Dermatol; 2013 Apr; 40(4):294-6. PubMed ID: 23397985
    [No Abstract]   [Full Text] [Related]  

  • 7. Serum YKL-40 predicts long-term mortality in patients with stable coronary disease: a prognostic study within the CLARICOR trial.
    Harutyunyan M; Gøtze JP; Winkel P; Johansen JS; Hansen JF; Jensen GB; Hilden J; Kjøller E; Kolmos HJ; Gluud C; Kastrup J
    Immunobiology; 2013 Jul; 218(7):945-51. PubMed ID: 23294528
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The inflammatory biomarker YKL-40 as a new prognostic marker for all-cause mortality in patients with heart failure.
    Harutyunyan M; Christiansen M; Johansen JS; Køber L; Torp-Petersen C; Kastrup J
    Immunobiology; 2012 Jun; 217(6):652-6. PubMed ID: 22209156
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum YKL-40: a potential biomarker for psoriasis or endothelial dysfunction in psoriasis?
    Erfan G; Guzel S; Alpsoy S; Rifaioglu EN; Kaya S; Kucukyalcın V; Topcu B; Kulac M
    Mol Cell Biochem; 2015 Feb; 400(1-2):207-12. PubMed ID: 25421412
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum YKL-40 as a potential biomarker of inflammation in psoriasis.
    Baran A; Myśliwiec H; Szterling-Jaworowska M; Kiluk P; Świderska M; Flisiak I
    J Dermatolog Treat; 2018 Feb; 29(1):19-23. PubMed ID: 28498006
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effects of Guizhi Fuling Decoction on YKL-40 and hs-CRP of patients with non-ST segment elevation acute coronary syndrome].
    Pei Q; Sang WF; Zhao XD
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2013 Feb; 33(2):186-90. PubMed ID: 23646472
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in C-reactive protein in patients with moderate-to-severe psoriasis switched to adalimumab therapy after suboptimal response to etanercept, methotrexate or phototherapy.
    Strober BE; Poulin Y; Teller C; Wang Y; Williams DA; Goldblum OM
    J Eur Acad Dermatol Venereol; 2014 Dec; 28(12):1701-6. PubMed ID: 24422992
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atherosclerosis, some serum inflammatory markers in psoriasis.
    Alpsoy S; Akyuz A; Erfan G; Akkoyun DC; Topcu B; Guzel S; Kaya S; Kulac M
    G Ital Dermatol Venereol; 2014 Apr; 149(2):167-75. PubMed ID: 24819636
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma YKL-40 and recovery of left ventricular function after acute myocardial infarction.
    Hedegaard A; Ripa RS; Johansen JS; Jørgensen E; Kastrup J
    Scand J Clin Lab Invest; 2010 Apr; 70(2):80-6. PubMed ID: 20102300
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum C-reactive protein levels in Japanese patients with psoriasis and psoriatic arthritis: Long-term differential effects of biologics.
    Asahina A; Umezawa Y; Yanaba K; Nakagawa H
    J Dermatol; 2016 Jul; 43(7):779-84. PubMed ID: 26704718
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel inflammatory marker in dialysis patients: YKL-40.
    Okyay GU; Er RE; Tekbudak MY; Paşaoğlu Ö; Inal S; Öneç K; Paşaoğlu H; Altok K; Derici Ü; Erten Y
    Ther Apher Dial; 2013 Apr; 17(2):193-201. PubMed ID: 23551676
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differentiating Psoriatic Arthritis From Psoriasis Without Psoriatic Arthritis Using Novel Serum Biomarkers.
    Cretu D; Gao L; Liang K; Soosaipillai A; Diamandis EP; Chandran V
    Arthritis Care Res (Hoboken); 2018 Mar; 70(3):454-461. PubMed ID: 28586166
    [TBL] [Abstract][Full Text] [Related]  

  • 18. YKL-40 levels and atrial fibrillation in the general population.
    Marott SC; Benn M; Johansen JS; Jensen GB; Tybjærg-Hansen A; Nordestgaard BG
    Int J Cardiol; 2013 Aug; 167(4):1354-9. PubMed ID: 22525348
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chitinase-3-like protein 1 (YKL-40) is a biomarker of severity of joint involvement in psoriatic arthritis.
    Salomon J; Matusiak Ł; Nowicka-Suszko D; Szepietowski JC
    Postepy Dermatol Alergol; 2018 Oct; 35(5):485-489. PubMed ID: 30429706
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum YKL-40 is increased in patients with slow coronary flow.
    Xu Y; Meng HL; Su YM; Chen C; Huang YH; Li XF; Fan MK; Yan YJ; Wu J; Jiang MH; Pan M
    Coron Artery Dis; 2015 Mar; 26(2):121-5. PubMed ID: 25356814
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.